The Daily Pulse

Health• Updated

Chronic inflammation emerges as a major driver in cancer, heart disease, and aging

Reported by Pooja Nair (Section Editor) · The Hindu - Health ·

Unconfirmed — Reported by one source so far

Reported by one source so far

Worth knowing
Chronic inflammation emerges as a major driver in cancer, heart disease, and agingRepresentative image · Pexels

UPDATE - follow-up to Why is everything linked to inflammation now?: Chronic low-grade inflammation is now recognized by scientists as a key driver behind a wide range of serious health conditions, including cancer, heart disease, diabetes, and neurological disorders. Speaking on a recent podcast, cancer researcher and oncologist Siddhartha Mukherjee noted that thousands of dormant cancer cells sit in the human body, and chronic inflammation acts as the trigger that wakes them up. If medical professionals could test for this specific type of inflammation, it could serve as a preventative biomarker for future cancers. Recent studies highlight the severe physical toll of this immune over-stimulation. Research published in the European Journal of Preventive Cardiology shows that chronic inflammation raises the risk of heart attack and stroke by 43 percent, causing silent structural damage to the heart years before symptoms appear. Scientists from the MRC Laboratory of Medical Sciences and Imperial College London found this damage includes thickened walls and smaller chambers. Medical experts explain that unlike acute inflammation, which creates visible redness and swelling to heal wounds, chronic inflammation is silent and persistent. Factors such as poor diet, air pollution, sleep debt, lack of movement, and constant stress fuel this condition. Arpit Bansal, oncology surgeon and chief scientific chair at the Longevity Summit India, describes modern life's inflammation triggers through five faces, including ultra-processed food and a state of constant mental stimulation known as the red mind. This continuous immune activation can cause the body to attack its own cells, leading to autoimmune diseases such as rheumatoid arthritis, psoriasis, and Hashimoto's disease. Dr. Vinaya Bhandari, a neurology specialist at Mumbai's Jaslok Hospital and Research Centre, explains that inflammatory signals interact with the brain and its blood vessels, contributing to neurodegenerative conditions like Alzheimer's and Parkinson's. Similarly, Dr. Aditya Vidushi, a medical oncologist at Faridabad's M|O|C Cancer Care & Research Centre, notes that long-term irritation from conditions like H. pylori and obesity-related inflammation promotes malignant transformations in gastric, breast, and liver cancers. Researchers are also finding regional vulnerabilities. Senthilkumar Rajagopal, associate professor at REVA University in Bengaluru, states that South Asian populations may have a unique susceptibility to chronic low-grade inflammation due to a mix of genes, visceral fat, insulin resistance, and lifestyle factors. While the wellness industry has capitalized on this scientific shift by marketing anti-inflammatory products, supplements, and lifestyle cleanses, doctors advise caution, noting that detecting chronic inflammation requires clinical tests like C-Reactive Protein, though results can sometimes be elusive.

ExplainerWhy this matters

What Happened

Scientists and medical researchers have increasingly linked chronic, low-level immune system activation to major chronic illnesses like cancer, heart disease, and Alzheimer's, shifting public and clinical focus away from just visible, acute inflammation.

Why It Matters

Understanding that silent inflammation drives serious diseases changes how modern medicine approaches prevention and treatment. Instead of treating isolated symptoms after they appear, researchers aim to use inflammatory markers as early warning signs for conditions like heart attacks and cancer years before physical symptoms manifest.

What Happens Next

Researchers around the world are continuing clinical studies to track inflammation markers over time in patients, aiming to establish clear baselines for what constitutes dangerous levels of chronic inflammation and how molecular pathways between neurons and immunity can be targeted.

Read more at The Hindu - Health →